BSX's acquisition of Axonics marks its entry into sacral neuromodulation and complements its Urology business.

Boston Scientific announced the acquisition in January, but the review dragged on after the Federal Trade Commission ...

Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).

Boston Scientific Corp. last week announced that it has closed on its acquisition of Irvine-based medical device maker ...

MARLBOROUGH, Mass., Nov. 15, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a medical technology ...

Boston Scientific (BSX) announced the close of its acquisition of Axonics (AXNX). The purchase price of $71 cash per share represents an ...

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: ...

MARLBOROUGH, Mass. - Boston Scientific Corporation (NYSE:BSX) has finalized its acquisition of Axonics, Inc. (NASDAQ:AXNX), a company specializing in medical devices for urinary and bowel ...

MARLBOROUGH, Mass. - Boston Scientific Corporation (NYSE:BSX) has finalized its acquisition of Axonics, Inc. (NASDAQ:AXNX), a company specializing in medical devices for urinary and bowel dysfunction, ...